ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

HYPERRAB S/D
Vaccines
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

HYPERRAB S/D Rx

Generic Name and Formulations:
Rabies immune globulin (human) 150 IU/mL; soln for IM inj; preservative-free; latex-free.

Company:
Grifols Biologicals, Inc.

Therapeutic Use:

Indications for HYPERRAB S/D:

Postexposure prophylaxis of rabies.

Adult:

See literature. Give by IM inj preferably at the time of 1st vaccine dose; may be given through 7th day after 1st vaccine dose is given. 20 IU/kg (0.133mL/kg) once. If feasible, up to full dose should be infiltrated in area around wound and the rest into deltoid muscle of upper arm or lateral thigh muscle.

Children:

Not recommended.

Warnings/Precautions:

Previously immunized with rabies vaccine with a confirmed adequate rabies antibody titer: not recommended. Contains human plasma; monitor for possible infection transmission. IgA-deficiency. Thrombocytopenia or other bleeding disorders. Prior history of allergic reactions to human immunoglobulins. Have epinephrine inj available. Pregnancy (Cat.C).

Interactions:

Avoid live vaccines within 3 months.

Pharmacological Class:

Immune globulin.

Adverse Reactions:

Inj site reactions, mild temp elevations; rare: angioneurotic edema, rash, nephrotic syndrome, anaphylactic shock.

How Supplied:

Single-use vial (2mL, 10mL)—1

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs